Mazor Robotics Receives Second Purchase Order for Renaissance System From Russia Distribution Partner Neuroproject Ltd.
9/26/2013 10:39:27 AM
CAESAREA, Israel--(BUSINESS WIRE)--Mazor Robotics Ltd. (TASE: MZOR) (NASDAQCM: MZOR), the developer of Renaissance™, an innovative surgical guidance system and its complementary products, announced today that it received a Renaissance system order from its Russian distribution partner, Neuroproject Ltd. Russia remains an important market for the Company, as it now has a total of six surgical guided systems installed, primarily in Moscow. Neuroproject Ltd. will place the Renaissance system at City Clinical Hospital, #67, which is part of the Moscow City HealthCare Department. City Clinical Hospital, #67, is one of the largest multi-field medical and preventive treatment facilities of Moscow. The hospital employs highly skilled professionals, including 5 Doctors of Medical Science and 45 Candidates of Medical Science; more than 100 physicians have the highest qualification class. More than 14,000 surgeries are performed annually, including a great number of high-tech ones, such as spine surgery. The hospital is a clinical site for 11 sub departments of Moscow’s medical universities.
Help employers find you! Check out all the jobs and post your resume.
comments powered by